Prostate Cancer - Results from #1280

A Phase I Trial of Salvage Stereotactic Body Radiation Therapy for Radiorecurrent Prostate Cancer After Brachytherapy. March 4, 2024

Secondary analysis of late major gastrointestinal and genitourinary toxicities in unfavorable-risk prostate cancer patients receiving docetaxel: Insights from a randomized trial. March 4, 2024

Genomic evolution shapes prostate cancer disease type. March 4, 2024

Healthy dietary patterns and risk of prostate cancer in men at high genetic risk. March 4, 2024

A phase 2 study of AZD4635 in combination with durvalumab or oleclumab in patients with metastatic castration-resistant prostate cancer. March 4, 2024

Combining CAPRA-S With Tumor IDC/C Features Improves the Prognostication of Biochemical Recurrence in Prostate Cancer Patients. March 4, 2024

Terminating Cancer by Blocking VISTA as a Novel Immunotherapy: Hasta la vista, baby March 1, 2024

The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2. March 1, 2024

CRM1 regulates androgen receptor stability and impacts DNA repair pathways in prostate cancer, independent of the androgen receptor. March 1, 2024

Evaluation of Survival Outcomes Among Black and White Patients with Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis. March 1, 2024

Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes. March 1, 2024

Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer. March 1, 2024

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part II: Treatment Delivery for Non-metastatic Biochemical Recurrence After Primary Radical Prostatectomy. March 1, 2024

Characterizing the real-world economic burden of metastatic castration-sensitive prostate cancer in the United States. March 1, 2024

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy. March 1, 2024

Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part III: Salvage Therapy After Radiotherapy or Focal Therapy, Pelvic Nodal Recurrence and Oligometastasis, and Future Directions. March 1, 2024

Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial. March 1, 2024

Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients. February 29, 2024

Prostatic Artery Embolization in Patients with Advanced Prostate Cancer: A Prospective Single Center Pilot Study. February 29, 2024

Radical prostatectomy cancer grade and percentage of Gleason pattern 4 estimated by global vs individual tumor grading correlate differently with the risk of biochemical recurrence in Grade Group 2 and 3 cancers. February 29, 2024

Page 65 of 1436